Jeyabaskar Suganya, G. Rajesh Kumar, Mahendran Radha, Dhananya S
firstname.lastname@example.org , email@example.com
Jeyabaskar Suganya1, G. Rajesh Kumar2, Mahendran Radha3*, Dhananya S4
1Assistant Professor, Department of Bioinformatics, School of Life Sciences, VISTAS, Chennai - 600117, Tamil Nadu, India.
2Assistant Professor, Department of Pharmacology, Govt. Kilpauk Medical College, Chennai, Tamil Nadu, India.
3Professor, Department of Bioinformatics, School of Life Sciences, VISTAS, Chennai - 600117, Tamil Nadu, India.
4Student, Department of Bioinformatics, School of Life Sciences, VISTAS, Chennai - 600117, Tamil Nadu, India.
Volume - 14,
Issue - 12,
Year - 2021
Nature has bestowed on us a very rich botanical wealth. Plants are the richest resource of drugs molecules for modern medicines, nutraceuticals, traditional medicine and even chemical entities for synthetic drugs. Ocimum species (Tulasi) is a well-known medicinal plant which has used in the six Indian systems of medicine from ancient times. The latest review on the Ocimum species revealed that the species holds a very good antiviral activity. For last few years the prevalence of dengue has increased dramatically in both urban and rural area of India. The current management of Dengue is mainly symptomatic and supportive treatment with fluid management. The main purpose of this study was to analyze the inhibitory action of phytochemical compounds were identified from the plant species Ocimum through literature survey by computational docking studies. Thus docking result revealed that only one compound Bornyl acetate exhibited the best binding interaction with in the active site of the dengue viral protein through hydrogen bonding interaction. Further in vitro studies on Bornyl acetate compounds from the Ocimum species can lead to the discovery of novel viral inhibitor.
Cite this article:
Jeyabaskar Suganya, G. Rajesh Kumar, Mahendran Radha, Dhananya S. In silico Investigation of Natural compounds identified from Ocimum species as Dengue NS3 and NS5 Protein Inhibitors. Research Journal of Pharmacy and Technology. 2021; 14(12):6621-6. doi: 10.52711/0974-360X.2021.01144
Jeyabaskar Suganya, G. Rajesh Kumar, Mahendran Radha, Dhananya S. In silico Investigation of Natural compounds identified from Ocimum species as Dengue NS3 and NS5 Protein Inhibitors. Research Journal of Pharmacy and Technology. 2021; 14(12):6621-6. doi: 10.52711/0974-360X.2021.01144 Available on: https://rjptonline.org/AbstractView.aspx?PID=2021-14-12-74
1. Joseph Keating. An investigation into the cyclical incidence of dengue fever. Social Science and Medicine. 2002; 53(12): 1587-97.
2. Ekta Gupta and Neha Ballani. Current perspectives on the spread of dengue in India. Infect Drug Resist. 2014; 7: 337-342.
3. Anne Tuiskunen Back and Ake Lundk vist. Dengue viruses-an overview. Infect Ecol Epidemiol. 2013; 3: 19839.
4. Abbas El Sahili and Julien Lescar. Dengue Virus Non-Structural Protein 5. Viruses. 2017; 9(4): 91.
5. Nishat Hussain Ahmed and Shobha Broor. Dengue Fever Outbreak in Delhi, North India: A Clinico-Epidemiological Study. Indian J Community Med. 2015; 40(2): 135-138.
6. André S. de Oliveira, Milene Lopes da Silva, Ana Flávia C. S. Oliveira, Cynthia Silva. NS3 and NS5 proteins: Important Targets for Anti-Dengue Drug Design, J. Braz. Chem. Soc. 2014; 25(10): 1759-69.
7. Silva EM, Conde JN, Allonso D. Dengue Virus Nonstructural 3 protein interacts directly with human glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and reduces its glycolytic activity. Sci Rep. 2019; 9: 265.
8. Abbas El Sahili and Julien.Lescar. Dengue Virus Non-Structural Protein 5. Viruses. 2017; 9: 91.
9. Jenny GH Low, Eng Eong Ooi and Subhash G Vasudevan. Current Status of Dengue Therapeutics Research and Development. J Infect Dis. 2017; 215(Suppl 2): S96-S102.
10. Sabah AA Jassim and Naji MA. Novel antiviral agents: A medicinal plant perspective. J Appl Microbiol. 2003; 95(3): 412-27.
11. Siew pheng Lim, Qing-Yin Wang and Yen-Liang Chen. Ten years of dengue drug discovery: Progress and prospects. Antiviral Res. 2013; 100(2): 500-19.
12. Radha Mahendran, Suganya Jeyabasker, Astral Francis and Sharanya Manoharan. Insights into the Identification of p38-alpha Mitogen activated Protein Kinase against Pyridazinopyridinone Derivatives in the Treatment of Rheumatoid Arthritis. Research J Pharm and Tech. 2017; 10(9): 2875-2879.
13. Jeyabaskar Suganya, Mahendran Radha, Sharanya Manoharan, Vinoba. V and Astral Francis. Virtual Screening and Analysis of Bioactive Compounds of Momordica charantia against Diabetes using Computational Approaches. Research J Pharm and Tech. 2017; 10(10): 3353-3360.
14. Jeyabaskar Suganya, Mahendran Radha and Hubert. Computational studies on Differential gene Expression in Malaria Microarray Dataset. Research J. Pharm. and Tech 2020; 13(3): 1368-1376
15. Maheswata Sahoo, Lingaraja Jena, Daf Sangeeta and Satish Kumar. Virtual Screening for Potential Inhibitors of NS3 Protein of Zika Virus. Genomics Inform. 2016, 14(3): 104-111.
16. Mahendran Radha, Vyshnavie Ratnasabapathysarma and Jeyabaskar Suganya. In Silico approach to inhibit Synthetic HIV-TAT activity using Phytoconstituents of Moringa oleifera leaves extract. Research J. Pharm. and Tech. 2020; 13(8): 3610-3614
17. Nataraj S Pagadala, Khajamohiddin Syed and Jack Tuszynski. Software for molecular docking: a review. Biophys Rev. 2017; 9(2): 91-102.
18. Ravishankar B and Shukla VJ. Indian systems of medicine: a brief profile. Afr J Tradit Complement Altern Med., 2007; 4(3): 319-337.
19. Atanas G Atanasov, Birgit Waltenberger, Eva-Maria, Pferschy-Wenzig, Thomas Linder, Discovery and resupply of pharmacologically active plant-derived natural products: A review. Biotechnol Adv. 2015, 33(8): 1582-1614.
20. Jeyabaskar Suganya, Viswanathan T, Mahendran Radha, Rathisre PR, Nishandhini Marimuthu. Comparative Quantitative Screening of Secondary Phytoconstituents from the leaves extract of Sterculia foetida Linn. Research J. Pharm. and Tech. 2017; 10(9): 2907-2912
21. Nishandhini Marimuthu, Viswanathan T, Mahendran Radha, Rathisre. P.R, Jeyabaskar Suganya. Preliminary analysis of Phyto-constituents from the Leaf Extracts of Ballota nigra Linn. Research J. Pharm. and Tech. 2017; 10(1): 161-165
22. Rajesh Kumar Ganjhu, Piya Paul Mudgal, Hindol Maity, et al. Herbal plants and plant preparations as remedial approach for viral diseases. Virus disease. 2015; 26(4): 225-236.
23. Amol Deshmukh, Girishkumar B Deshmukh and Pratibha D Shirole. Ocimum Sanctum: A Medicinal Gift from Nature. IJPSR. 2015; 2(12): 550-59.
24. Bhaskar Kallappa Kurangi and Sunil Satyappa Jalalpure. Review of selected herbal phytoconstituents for potential melanoma treatment. Indian J Health Sci Biomed Res. 2018; 11(1): 3-11.
25. Dominguez GM, Mpewo JT, Miriela BV and Jose Luis Cadenas Freixas. Inflammation Modulation with Methanol Zea Mays Cob Husk on an Experimental Model in Albino Rats. Revista Cubana de Investigaciones Biomedicas. 2019; 38(1): e150.
26. Jeyabaskar Suganya, Viswanathan T, Mahendran Radha, Rathisre PR and Nishandhini Marimuthu. In vitro Antibacterial Activity of different crude leaves extracts of Sterculia foetida Linn. Research J. Pharm. and Tech. 2017; 10(7): 2013-2017
27. Marjorie Murphy Cowan. Plant Products as Antimicrobial Agents. Clin Microbiol Rev. 1999; 12(4): 564-582.
28. Muhammad Tahir ul Qamar, Arooma Maryam, Iqra Muneer and Feng Xing. Computational screening of medicinal plant phytochemicals to discover potent pan-serotype inhibitors against dengue virus. Sci Rep. 2019; 9: 1433.
29. Prakhar Shukla, Sweta Sharma, Arpita Yadav, Veejendra K Yadav. Synergistic pharmacological Effects of Phytochemicals Derived from Ginger, Garlic and Tulsi. Int J Pharm Sci Res. 2015; 6(12): 4967-81.
30. Amit Kumar and Priyanka Mishra. Higher efficiency of ISSR markers over plastid psbA-trnH region in resolving taxonomical status of genus Ocimum L. Ecology and Evolotion. 2016; (21): 7671-7682.
31. Cristina M Uritu, Cosmin T Mihai, Gabriela-Dumitrita Stanciu and Gianina Dodi. Medicinal Plants of the Family Lamiaceae in Pain Therapy: A Review. Pain research and management. 2018; 7801543: 44.
32. Kumar A, Agarwal K, Maurya AK, Shanker, Bushra, Tandon and Bawankule DU. Pharmacological and phytochemical evaluation of Ocimum sanctum root extracts for its anti-inflammatory, analgesic and antipyretic activities. Pharmacogn Mag. 2015; 11(Suppl 1): S217-24.
33. Bilal Ahmad, Usman Ali Ashfaq, Muhammad Tahir U Qamar and Matloob Ahmad. Anticancer potential of phytochemicals against breast cancer: Molecular docking and simulation approach, Bangladesh Journal of Pharmacology. 2014; 9(4): 545-50.
34. Jeyabaskar Suganya, Viswanathan T, Mahendran Radha, Nishandhini Marimuthu. In silico Molecular Docking studies to investigate interactions of natural Camptothecin molecule with diabetic enzymes. Research J. Pharm. and Tech. 2017; 10(9): 2917-2922
35. Stefano Forli, Ruth Huey, Michael E Pique, Michel Sanner, David S Goodsell and Arthur J Olson. Computational protein-ligand docking and virtual drug screening with the AutoDock 18.104.22.168.6suite. Nature Protocols. 2016; 11: 905-919.
36. Jeyabaskar Suganya, Sharanya Manoharan, Mahendran Radha, Neha Singh and Astral Francis. Identification and Analysis of Natural Compounds as Fungal Inhibitors from Ocimum sanctum using in silico Virtual Screening and Molecular Docking. Research J. Pharm. and Tech. 2017; 10(10):3369-3374.
37. Luo D, Xu T, Hunke C, Gruber G, Vasudevan SG and Lescar J. Crystal structure of the NS3 protease-helicase from dengue virus. J Virol. 2008; 82(1): 173-83.
38. Zengming Zhang, Yu Li and Biaoyang Lin. Identification of cavities on protein surface using multiple computational approaches for drug binding site prediction. Bioinformatics. 2011; 27(15): 2083-8.
39. Babita Labh Kayastha. Queen of Herbs Tulsi (Ocimum sanctum) Removes Impurities from Water and Plays Disinfectant Role. Journal of Medicinal Plants Studies. 2014; 2(2): 1-8.
40. Sheng Tian, Junmei Wang, Youyong Li and Dan Lei. The application of in silico drug-likeness predictions in pharmaceutical research. Adv Drug Deliv Rev. 2015; 86: 2-10.
41. Antoine Daina., Olivier Michielin., Vincent Zoete,. SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci Rep. 2017; 3(7): 42717.
42. Giovanni Bocci, Emanuele Carosati, Philippe Vayer, Alban Arrault, Sylvain Lozano and Gabriele Cruciani. ADME-Space: a new tool for medicinal chemists to explore ADME properties. Sci Rep. 2017; 7: 6359.
43. 13.Crystall MD, Swarbrick, Chandrakala Basavannacharya, et al. NS3 helicase from dengue virus specifically recognizes viral RNA sequence to ensure optimal replication. Nucleic Acids Res. 2017; 45(22): 12904-12920.
44. Dahai Luo, Ting Xu Cornelia Hunke, Gerhard Gruber, Subhash G Vasudevan and Julien Lescar. Crystal Structure of the NS3 Protease-Helicase from Dengue Virus. J Virol. 2008; 82(1): 173-183.
45. Jerome de Ruyck, Guillaume Brysbaert, Ralf Blossey and Marc F Lensink., Molecular docking as a popular tool in drug design, an in silico travel. Adv Appl Bioinform Chem. 2016; 9: 1-11
46. Pankaj Gautam. Antiviral Potential of Medicinal Plants: An Overview. Int. Res. J.Pharm. 2013; 4(6): 8-16.
47. Siva M, Shanmugam KR, Shanmugam B, et al. Ocimum sanctum: A Review on the Pharmacological Properties. International Journal of Basic and Clinical Pharmacology. 2016; 5(3): 558-565.
48. Michela Bollati, Karin Alvarez and Rene Assenberg. Structure and functionality in flavivirus NS-proteins: Perspectives for drug design. Antiviral Res. 2010; 87(2): 125-148.
49. Radha Mahendran, Suganya Jeyabasker, Astral Francis and Sharanya Manoharan. Homology Modeling and in silico docking analysis of BDNF in the treatment of Alzheimer’s disease. Research J. Pharm. and Tech. 2017; 10(9): 2899-2906
50. Balani SK. Miwa GT. Gan LS. Wu JT and Lee FW. Strategy of utilizing in vitro and in vivo ADME tools for lead optimization and drug candidate selection. Current Topics in Medicinal Chemistry. 2005; 5(11): 1033-8.
51. Lucky S Mulwa and Marc Stadler. Antiviral Compounds from Myxobacteria. Microorganisms. 2018; 6(3): 73.
52. Xuan-Yu Meng, Hong-Xing Zhang, Mihaly Mezei and Meng Cui. Molecular Docking: A powerful approach for structure-based drug discovery. Curr Comput Aided Drug Des. 2011; 7(2): 146-157.
53. Hayes EB. Zika virus outside Africa. Emerg Infect Dis. 2009; 15: 1347-1350.
54. Renu Kadian and Milind Parle. Theraupatic potential and phytopharmacology of Tulsi. Int. J. of Pharm. & Life Sc. 2012; 3(7): 1858-1867.
55. Sukhdev Singh, Bhupender Sharma, Shamsher S Kanwar and Ashok Kumar. Lead phytochemicals for anticancer drug development. Front Plant Sci. 2016; 7: 1667.
56. Totsika Makrina, Dimitrios Vagenas. Jason J Paxman, Geqing Wang, Rabeb Dhouib and Pooja Sharma. Inhibition of Diverse DsbA Enzymes in Multi-DsbA Encoding Pathogens. Antioxidants & Redox Signaling. 2017; 1(1): 1-14.
57. Van de Wakker, Fischer MJE and Oosting RS. New drug-strategies to tackle viral-host interactions for the treatment of influenza virus infections. Eur J Pharmacol. 2017; 809: 178-190.